Objectives Transcatheter aortic valve implantation (TAVI) is a promising new technology which is typically used to treat elderly patients with severe aortic stenosis who cannot undergo surgical aortic valve replacement due to high risk factors.
Methods We hereby present the case of a 70-year-old woman patient with severe aortic stenosis who underwent decompensated heart failure. This patient was judged inoperable and then scheduled for transfemoral CoreValve Revalving System implantation.
Results This patient was judged inoperable and then scheduled for transfemoral CoreValve Revalving System implantation. The procedural was successful, no complication, the gradient from ventrical to aortic artery dispeared. At 2 years of follow-up, heart function improve. There was no flow disturbance around the valve and no gradient from ventrical to aortic artery. There was no stroke and arrhythmia.
Conclusions This patient is one of the earliest to accept the TAVI in China, the clinical outcome is favorable.